Jubilant Pharmova Ltd.

JUBLPHARMA

Market Cap
₹11,176 Cr.
P/E
295.19

Jubilant Pharmova Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics
Other Income
Other Income is not affecting ratios of the company
Capex vs ROCE
ROCE of the company has decreased even without significant capex
Depreciation Effect
Company is depreciating a greater percentage of assets. This is contributing to a reduction in Net Profit
Pledge
Promoters have not pledged a significant portion of their holding
Revenue Recognition
Company is converting accounting profit to cash
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
Retail has been buying the stock which is usually a sign of exuberance
Share price
Share price has increased over last 10 years but more due to rerating
ROE
Asset Turnover is responsible for ROE increase over last 10 years
Working Capital
Working Capital of the company seems to be under control
Debt
Company might have issues servicing its debt
Promoter Holding
Promoter has not sold any shares in the last 90 days
Current vs Historic Valuation
Company is trading at a premium to 3 year historic valuations
ROE
Latest
-1.13%
3yr Average
8.09%
5yr Average
10.45%
Net Profit Margin
Latest
-0.97%
3yr Average
6.5%
5yr Average
8.16%
ROCE
Latest
2.85%
3yr Average
8.73%
5yr Average
10.85%
Debt to Equity
Latest
0.63
3yr Average
0.58
5yr Average
0.71
Market Share
62% (as of Mar 18)
Acetic Anhydride - Domestic Market Share
0.06% (as of Jul 22)
Anti - Diabetes - Market Share
0.06% (as of Jul 22)
Cardiovascular - Market Share
0.01% (as of Feb 21)
Neurological - Market Share
0.02% (as of Jul 22)
Pharmaceutical Sector - Market Share
0.03% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
18% (as of Mar 18)
Vitamin B3 - Global Market Share
64% (as of Mar 18)
Vitamin B4 - Domestic Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Segment Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up -Contract Research

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up -Pharmaceuticals

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Operating Profit Break-Up

locked
Source
|
Latest
|
locked
Historic

Capex

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • Australia DMF fillings (.)
      Source
    • US DMF Filings (.)
      Source
    • Canada DMF fillings (.)
      Source
    • Japan DMF Filings (.)
      Source
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • Number of ANDA's Filed in Europe
      Source
    • Number of ANDA's Approved in Europe
      Source
    • Number of ANDA's Filed in Canada
      Source
    • Number of ANDA's Approved by Canada
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Jubilant Pharmova Ltd.
    View the discussion on ValuePickr
    Jubilant vs Syngene in CDMO - UnseenValue
    Chemical Sector
    Chemicals Sector - Breakdown and Value Chain - PPFAS
    Chemical Industry - Top Down - Capital Mind
    Battery Chemistry Of EV's - Value Educator
    Indian agrichemical overview - a sectoral perspective - ValuePickr
    Next MegaTrend in Investing : Is Methanol Next "Ethanol"? - Sadhan
    Understanding the Agri-Inputs Industry - PPFAS
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline